Protagonist Therapeutics, Inc.
.alpha.4.beta.7 thioether peptide dimer antagonists
Last updated:
Abstract:
The invention relates to thioether monomer and dimer peptide molecules which inhibit binding of .alpha.4.beta.7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo.
Status:
Grant
Type:
Utility
Filling date:
19 Jul 2018
Issue date:
21 Apr 2020